Pharmacy Curriculum Outcomes Assessment (PCOA) Practice Exam 2026 - Free Pharmacy Practice Questions and Study Guide

Question: 1 / 400

Zanamivir (Relenza) is indicated for the treatment of:

Tuberculosis

Influenza A

Zanamivir (Relenza) is an antiviral medication that is used to treat uncomplicated influenza A and B. It is not indicated for the treatment of tuberculosis, hepatitis B or the common cold. Tuberculosis is a bacterial infection and is usually treated with antibiotics. Hepatitis B is a viral infection and has its own specific treatment options. The common cold is caused by a virus and does not have a specific treatment, usually just managing symptoms is recommended. Zanamivir specifically targets and inhibits the influenza virus, making it an effective treatment for this specific illness.

Get further explanation with Examzify DeepDiveBeta

Hepatitis B

Common cold

Next Question

Report this question

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy